ANIKORA
Live / Registered — Registered (as of 24 Sept 2024)
What this means for you
Registered since 24 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97523022
- Registration number
- 7510795
- Mark type
- Stylized text
- Filed
- 27 Jul 2022
- Published for opposition
- 09 Jul 2024
- Registered
- 24 Sept 2024
- Attorney of record
- Robert J. Kenney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; vaccines; biochemical medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; chemico-pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; biological preparations for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hemoglobin; medicines for human purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; drugs for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hematogen for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; injectable medicinal solutions for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia
Owner
- CTTQ-Akeso (Shanghai) Biomed. Tech. Co., Ltd., Baoshan, Shanghai, CN
- CTTQ-Akeso (Shanghai) Biomed. Tech. Co., Ltd., Baoshan, Shanghai, CN
- CTTQ-Akeso (Shanghai) Biomed. Tech. Co., Ltd., Baoshan, Shanghai, CN
Prosecution history
- 24 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 09 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jul 2024 — PUBLISHED FOR OPPOSITION
- 19 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Jun 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Jun 2024 — EXAMINER'S AMENDMENT ENTERED
- 04 Jun 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 04 Jun 2024 — EXAMINERS AMENDMENT E-MAILED
- 04 Jun 2024 — EXAMINERS AMENDMENT -WRITTEN
- 09 May 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 May 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 May 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 08 May 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 May 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED